Minolast-FXA Tablet SR
Minolast-FXA Tablet SR
Montelukast (10mg) + Fexofenadine (120mg) + Acebrophylline (200mg)
Cheaper alternative availability
Already at the Best Price
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
About This Medicine
Product description & overview
Minolast-FXA Tablet SR is a once-daily, delayed-release formulation of montelukast, fexofenadine, and acebrophylline, designed to provide comprehensive relief from respiratory and allergic symptoms. The combination of montelukast, a leukotriene receptor antagonist, and fexofenadine, a non-sedating antihistamine, addresses the root causes of allergic rhinitis and chronic asthma. Montelukast's action on leukotrienes helps to reduce bronchospasm and airway constriction, while fexofenadine's histamine-1 receptor blockade alleviates pruritus, sneezing, and runny nose. Acebrophylline, a phosphodiesterase inhibitor, enhances bronchodilation and improves respiratory function. In patients with moderate to severe allergic rhinitis and/or chronic asthma, Minolast-FXA Tablet SR provides long-lasting, 24-hour relief from nasal congestion, sneezing, runny nose, itchy eyes, and wheezing. This once-daily tablet is suitable for adults and children aged 12 years and above, offering a convenient and effective treatment option for those seeking comprehensive symptom management.
Active composition
Fexofenadine 120 mg
+2 more active ingredients
About Fexofenadine
Fexofenadine is a non-drowsy antihistamine used to treat allergic symptoms such as sneezing, runny nose, and itchy eyes. It works by blocking the action of histamine, which is responsible for allergy symptoms. Fexofenadine is effective in managing seasonal and perennial allergic rhinitis. In summary, Fexofenadine is beneficial for treating allergies.
How It Works
Fexofenadine selectively antagonizes H1 histamine receptors, inhibiting the effects of histamine in allergic reactions.
All Active Ingredients
Montelukast
Montelukast selectively antagonizes leukotriene receptors, inhibiting their effects on bronchoconstriction and inflammation.
Acebrophylline
Acebrophylline enhances mucociliary clearance by reducing mucus viscosity and promoting airway relaxation.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
Minolast-FXA Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Pregnancy
Information regarding the use of Minolast-FXA Tablet SR during breastfeeding is not available. Please consult your doctor.
Medical Advice
Driving
Minolast-FXA Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Minolast-FXA Tablet SR may be needed. Please consult your doctor.
Exercise Caution
Breastfeeding
Minolast-FXA Tablet SR may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Kidney
Minolast-FXA Tablet SR is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Minolast-FXA Tablet SR may not be needed in these patients. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Minolast-FXA Tablet SR
